[Malaria prevention. Chemotherapy and immune prophylaxis. 3. Immune response of infected organism. Perspectives of Malaria prevention].
Wagner
W H
WH
D000595:Amino Acid Sequence; D000818:Animals; D000917:Antibody Formation; D001402:B-Lymphocytes / Q000276:immunology; D000939:Epitopes / Q000032:analysis / Q000276:immunology; D004912:Erythrocytes / Q000166:cytology / Q000276:immunology; D000882:Haplorhini; D006801:Humans; D007106:Immune Sera / Q000235:genetics; D007111:Immunity, Cellular; D007113:Immunity, Innate; D007116:Immunization, Passive / Q000379:methods; D007167:Immunotherapy; D007231:Infant, Newborn; D008222:Lymphokines / Q000276:immunology / Q000502:physiology; D008264:Macrophages / Q000276:immunology; D008288:Malaria / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D051379:Mice; D010961:Plasmodium / Q000166:cytology / Q000276:immunology; D010966:Plasmodium vivax / Q000235:genetics / Q000276:immunology; D012100:Reproduction, Asexual; D013601:T-Lymphocytes / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D000939:Epitopes; D007106:Immune Sera; D008222:Lymphokines
Malariabekämpfung--Chemotherapie und Immunprophylaxe. 3. Mitteilung: Immunantwort des infizierten Organismus/Perspektiven der Malariabekämpfung.